Cerenova is developing technologies and treatments targeting neurological diseases inaccessible by existing pharmacological and device-based interventions.
Our technologies seek to restore function and provide increased personal independence to individuals with disabling neurological disorders, while reducing the economic impact of patient care.
Cerenova represents more than 30 years combined pre-clinical research, based on a partnership between two world-renowned research institutions.